New insights into genotype‑phenotype correlations in Chinese facioscapulohumeral muscular dystrophy: A retrospective analysis of 178 patients

Chinese Medical Journal

Volumn 128, Issue 13, 2015, Pages 1707-1713

  Lin, Feng ^a   Wang, Zhi Qiang ^a   Lin, Min Ting ^a   Murong, Shen Xing ^a   Wang, Ning ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Asymptomatic; Facio scapulohumeral muscular dystrophy; Genetic counseling; Phenotype

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SOUTHERN BLOTTING; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION; GENETICS; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PHENOTYPE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84933512698     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.159336     Document Type: Article

References (27)

1. Emery AE. Population frequencies of inherited neuromuscular diseases-A world survey. Neuromuscul Disord 1991;1:19-29.
2. Lunt PW, Compston DA, Harper PS. Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias. J Med Genet 1989;26:755-60.
3. Lunt PW, Harper PS. Genetic counselling in facioscapulohumeral muscular dystrophy. J Med Genet 1991;28:655-64.
4. Wijmenga C, Hewitt JE, Sandkuijl LA, Moerer P, Wright TJ, Williamson R, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992;2:26-30.
5. van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, Padberg GW, et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993;2:2037-42.
6. Wang ZQ, Wang N, van der Maarel S, Murong SX, Wu ZY. Distinguishing the 4qA and 4qB variants is essential for the diagnosis of facioscapulohumeral muscular dystrophy in the Chinese population. Eur J Hum Genet 2011;19:64-9.
7. Deidda G, Cacurri S, Piazzo N, Felicetti L. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). J Med Genet 1996;33:361-5.
8. Lemmers RJ, de Kievit P, Sandkuijl L, Padberg GW, van Ommen GJ, Frants RR, et al. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet 2002;32:235-6.
9. thJune 2010, LUMC, Leiden, The Netherlands. Neuromuscul Disord 2012;22:463-70.
10. Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, Dauwerse JG, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010;329:1650-3.
11. Wallace LM, Garwick SE, Mei W, Belayew A, Coppee F, Ladner KJ, et al. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 2011;69:540-52.
12. Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B, et al. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 1999;45:751-7.
13. Krasnianski M, Eger K, Neudecker S, Jakubiczka S, Zierz S. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion. Arch Neurol 2003;60:1421-5.
14. Ricci G, Scionti I, Sera F, Govi M, D’Amico R, Frambolli I, et al. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain 2013;136:3408-17.
15. Wu ZY, Wang ZQ, Murong SX, Wang N. FSHD in Chinese population: Characteristics of translocation and genotype-phenotype correlation. Neurology 2004;63:581-3.
16. Padberg GW, Lunt PW, Koch M, Fardeau M. Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord 1991;1:231-4.
17. Van Overveld PG, Enthoven L, Ricci E, Rossi M, Felicetti L, Jeanpierre M, et al. Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy. Ann Neurol 2005;58:569-76.
18. Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 1995;4:951-8.
19. Sacconi S, Lemmers RJ, Balog J, van der Vliet PJ, Lahaut P, van Nieuwenhuizen MP, et al. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. Am J Hum Genet 2013;93:744-51.
20. Lemmers RJ, Goeman JJ, Tawil R, Tapscott SJ, Bakker B, van der Maarel SM, et al. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Hum Mol Genet 2014;486:1-11.
21. Uncini A, Galluzzi G, Di Muzio A, De Angelis MV, Ricci E, Scoppetta C, et al. Facioscapulohumeral muscular dystrophy presenting isolated monomelic lower limb atrophy. Report of two patients with and without 4q35 rearrangement. Neuromuscul Disord 2002;12:874-7.
22. Kottlors M, Kress W, Meng G, Glocker FX. Facioscapulohumeral muscular dystrophy presenting with isolated axial myopathy and bent spine syndrome. Muscle Nerve 2010;42:273-5.
23. Hassan A, Jones LK Jr, Milone M, Kumar N. Focal and other unusual presentations of facioscapulohumeral muscular dystrophy. Muscle Nerve 2012;46:421-5.
24. Pastorello E, Cao M, Trevisan CP. Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy. Clin Neurol Neurosurg 2012;114:230-4.
25. Sakellariou P, Kekou K, Fryssira H, Sofocleous C, Manta P, Panousopoulou A, et al. Mutation spectrum and phenotypic manifestation in FSHD Greek patients. Neuromuscul Disord 2012;22:339-49.
26. Tonini MM, Passos-Bueno MR, Cerqueira A, Matioli SR, Pavanello R, Zatz M. Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord 2004;14:33-8.
27. Goto K, Nishino I, Hayashi YK. Very low penetrance in 85 Japanese families with facioscapulohumeral muscular dystrophy 1A. J Med Genet 2004;41:e12.